TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 26 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $29,373,729 | -20.4% | 45,400,000 | 0.0% | 0.33% | -24.7% |
Q2 2023 | $36,908,513 | -1.1% | 45,400,000 | +19.8% | 0.44% | -0.7% |
Q1 2023 | $37,317,810 | +8.0% | 37,900,000 | 0.0% | 0.44% | +23.2% |
Q4 2022 | $34,560,605 | -10.7% | 37,900,000 | 0.0% | 0.36% | -14.1% |
Q3 2022 | $38,693,000 | +3.8% | 37,900,000 | +2.4% | 0.42% | +11.8% |
Q2 2022 | $37,277,000 | +2.8% | 37,000,000 | +8.8% | 0.37% | +5.4% |
Q1 2022 | $36,271,000 | – | 34,000,000 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 45,000,000 | $474,089,000 | 9.50% |
ABSOLUTE INVESTMENT ADVISERS, LLC | 4,000,000 | $4,280,000 | 0.96% |
DeepCurrents Investment Group LLC | 22,150,000 | $23,650,000 | 0.74% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 19,000,000 | $19,967,000 | 0.46% |
Context Capital Management, LLC | 5,750 | $6,138,000 | 0.40% |
WOLVERINE ASSET MANAGEMENT LLC | 34,000,000 | $36,271,000 | 0.35% |
Polar Asset Management Partners Inc. | 15,000,000 | $15,993,000 | 0.17% |
LINDEN ADVISORS LP | 20,000,000 | $21,281,000 | 0.13% |
Wellesley Asset Management | 1,599 | $1,599,000 | 0.11% |
Verition Fund Management LLC | 6,213,000 | $6,614,000 | 0.08% |